Related references
Note: Only part of the references are listed.Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients
Atsumu Kouketsu et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2019)
Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
Anastasia Constantinidou et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review
Mustafa Ghanizada et al.
ORAL ONCOLOGY (2019)
Increase in detection of oral cancer and precursor lesions by dentists Evidence from an oral and maxillofacial pathology service
Aryan Abadeh et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2019)
Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma
Megumi Goto et al.
SCIENTIFIC REPORTS (2019)
Multiparameter Flow Cytometry Assay for Quantification of Immune Cell Subsets, PD-1 Expression Levels and PD-1 Receptor Occupancy by Nivolumab and Pembrolizumab
Dick Pluim et al.
CYTOMETRY PART A (2019)
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
Ling Li et al.
MODERN PATHOLOGY (2019)
Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma
Y. Maruse et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2018)
Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer
Shona Hendry et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Oral inflammation promotes oral squamous cell carcinoma invasion
Cameron Goertzen et al.
Oncotarget (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
Overexpression of immunomodulatory mediators in oral precancerous lesions
Andreia Souza Goncalves et al.
HUMAN IMMUNOLOGY (2017)
Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study
Matthias Troeltzsch et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2017)
PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability
Hans Brunnstrom et al.
MODERN PATHOLOGY (2017)
Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions
Takahiro Yagyuu et al.
ORAL ONCOLOGY (2017)
Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung Cancer
Wendy A. Cooper et al.
CLINICAL CANCER RESEARCH (2017)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer
Joseph McLaughlin et al.
JAMA ONCOLOGY (2016)
New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development
Jean-Philippe Foy et al.
CANCER PREVENTION RESEARCH (2015)
Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq
Caroline Conway et al.
ONCOTARGET (2015)
Neutrophils Increase Oral Squamous Cell Carcinoma Invasion through an Invadopodia-Dependent Pathway
Judah E. Glogauer et al.
CANCER IMMUNOLOGY RESEARCH (2015)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading
F. Dost et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2014)
The natural history of oral epithelial dysplasia: perspective on Dost et al.
Paul C. Edwards
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2014)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
The clinical determinants of malignant transformation in oral epithelial dysplasia
M. W. Ho et al.
ORAL ONCOLOGY (2012)
The Prognostic and Staging Implications of Bone Invasion in Oral Squamous Cell Carcinoma
Ardalan Ebrahimi et al.
CANCER (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management
Isaaec van der Waal
ORAL ONCOLOGY (2009)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Long-term treatment outcome of oral premalignant lesions
P. Holmstrup et al.
ORAL ONCOLOGY (2006)
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
C Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)